Skip to Content

717 5.4 WATSON (Yohimbine 5.4 mg)

Pill with imprint 717 5.4 WATSON is , and has been identified as Yohimbine hydrochloride 5.4 mg. It is supplied by Watson Pharmaceuticals.

Yohimbine is used in the treatment of erectile dysfunction; sexual dysfunction, ssri induced and belongs to the drug class impotence agents. FDA has not classified the drug for risk during pregnancy. Yohimbine 5.4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 717 5.4 WATSON

Yohimbine hydrochloride

717 5.4 WATSON
5.4 mg
Prescription only
Drug Class:
Impotence agents
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.